Form 8-K - Current report:
SEC Accession No. 0001437749-19-022681
Filing Date
2019-11-13
Accepted
2019-11-13 16:15:38
Documents
3
Period of Report
2019-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20191112_8k.htm 8-K 28487
2 EXHIBIT 99.1 ex_164715.htm EX-99.1 211387
3 logo01.jpg GRAPHIC 18167
  Complete submission text file 0001437749-19-022681.txt   266215
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 191214163
SIC: 2834 Pharmaceutical Preparations